Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|September 16, 2005
Jasmonates--a new family of anti-cancer agentsEliezer Flescher
Cancer Letters|April 8, 2006
Jasmonates in cancer therapyEliezer Flescher
Cellular Signalling|December 19, 2001
Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cellsEliezer Flescher, Ronit Rotem
Cancer Letters|November 28, 2006
Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucoseAlina Heyfets, Eliezer Flescher
Phytochemistry|August 8, 2009
Methyl jasmonate: a plant stress hormone as an anti-cancer drugSharon Cohen, Eliezer Flescher
Neoplasia (New York, N.Y.)|October 28, 2008
PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cellsUri Elia, Eliezer Flescher
Current Pharmaceutical Biotechnology|December 29, 2011
Combined chemotherapy or biotherapy with jasmonates: targeting energy metabolism for cancer treatmentUri Elia, Eliezer Flescher
Chemotherapy|May 6, 2006
Potential new antimalarial chemotherapeutics based on sphingolipid metabolismIrene Pankova-Kholmyansky, Eliezer Flescher
International Journal for Parasitology|February 26, 2008
Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalisKinneret Ofer, Daniel Gold, Eliezer Flescher
Journal of Bioenergetics and Biomembranes|June 6, 2007
Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate familyNatalia Goldin, Alina Heyfets, Dorit Reischer, et al.
Pageof 2